Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting frailty domain impairments and mortality with the Hospital Frailty Risk Score among older adults with cancer: the ELCAPA-EDS cohort study.
Jean C, Paillaud E, Boudou-Rouquette P, Martinez-Tapia C, Pamoukdjian F, Hagège M, Bréant S, Hassen-Khodja C, Natella PA, Cudennec T, Laurent M, Caillet P, Canouï-Poitrine F, Audureau E. Jean C, et al. Among authors: pamoukdjian f. Age Ageing. 2024 Oct 1;53(10):afae222. doi: 10.1093/ageing/afae222. Age Ageing. 2024. PMID: 39396910
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases.
Angeli E, Paris J, Le Tilly O, Desvignes C, Gapihan G, Boquet D, Pamoukdjian F, Hamdan D, Rigal M, Poirier F, Lutomski D, Azibani F, Mebazaa A, Herbet A, Mabondzo A, Falgarone G, Janin A, Paintaud G, Bousquet G. Angeli E, et al. Among authors: pamoukdjian f. Exp Hematol Oncol. 2024 Apr 15;13(1):41. doi: 10.1186/s40164-024-00513-7. Exp Hematol Oncol. 2024. PMID: 38622749 Free PMC article.
PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers.
Paris J, Wilhelm C, Lebbé C, Elmallah M, Pamoukdjian F, Héraud A, Gapihan G, Walle AV, Tran VN, Hamdan D, Allayous C, Battistella M, Van Glabeke E, Lim KW, Leboeuf C, Roger S, Falgarone G, Phan AT, Bousquet G. Paris J, et al. Among authors: pamoukdjian f. Clin Transl Med. 2024 Mar;14(3):e1632. doi: 10.1002/ctm2.1632. Clin Transl Med. 2024. PMID: 38515278 Free PMC article.
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment.
Couderc AL, Liuu E, Boudou-Rouquette P, Poisson J, Frelaut M, Montégut C, Mebarki S, Geiss R, Ap Thomas Z, Noret A, Pierro M, Baldini C, Paillaud E, Pamoukdjian F. Couderc AL, et al. Among authors: pamoukdjian f. Nutrients. 2023 Feb 27;15(5):1193. doi: 10.3390/nu15051193. Nutrients. 2023. PMID: 36904192 Free PMC article. Review.
Safety and efficacy of immunotherapy according to the age threshold of 80 years.
Mebarki S, Pamoukdjian F, Pierro M, Poisson J, Baldini C, Widad Lahlou, Taieb J, Fabre E, Canoui-Poitrine F, Oudard S, Paillaud E. Mebarki S, et al. Among authors: pamoukdjian f. Bull Cancer. 2023 May;110(5):570-580. doi: 10.1016/j.bulcan.2023.02.010. Epub 2023 Mar 7. Bull Cancer. 2023. PMID: 36894391 Free article. Review.
51 results